While subcutaneous injections provide 100% systemic bioavailability, oral mucosal delivery utilizes highly vascularized tissue under the tongue to absorb the peptides directly into the bloodstream
Key findings for semaglutide duration include continued weight loss through at least 68 weeks with no plateau in many patients, weight regain of approximately 40% of lost weight within seven months of stopping, and withdrawal effects including increased appetite, food cravings, and in some cases gastrointestinal changes
Expression values were obtained with the iterPLIER+16 algorithm and expressed in a log2 scale
Speakers: Ms Rmeysa Kuduban, Prof
Beyond nausea, the gastrointestinal side effect cluster includes diarrhea, vomiting, constipation, and decreased appetite, which is technically a desired effect but can become problematic at extreme levels